The chief of Serum Institute of India Adar Poonawalla announced that the company is looking forward to launch a second coronavirus vaccine, which if approved, could be India's third COVID-19 vaccine. Covishield has been developed by SII in partnership with the Oxford University and British-Swedish firm AstraZeneca.
https://ift.tt/eA8V8J from https://ift.tt/3cnZl8l
ليست هناك تعليقات:
إرسال تعليق